Navigation Links
Researchers Make Strides in VCJD Detection

A way of reversing brain impairment that strikes in the early stages of prion diseases such as vCJD and BSE has been identified by scientists.//

The findings suggest there may be a way to cure vCJD, the human form of BSE, if it can be detected before it has time to kill off large numbers of brain cells.

The disease has so far claimed the lives of 158 people in Britain, and seven more are known to be infected. But many scientists believe that thousands more may be harboring the disease but have yet to develop symptoms.

Prion diseases are caused when abnormal forms of natural proteins called prions get into the blood stream and force proteins already in the body to retract and suffocate brain cells.

Researchers led by Giovanna Malucci at the MRC prion unit at University College, London (UCL), used genetically modified mice to show that blocking the body's ability to make its own natural, healthy prions, reversed early symptoms of the disease.

They infected mice with abnormal prions and found they began to develop disease. But when the mice stopped producing their own prions, their symptoms cleared up.

"A psychologically healthy mouse will make nests and burrow, but they lose that early in the disease, they get withdrawn and depressed and lose their exploratory capacity," said Dr Malucci. "What we've shown is we can reverse that and get full functional recovery."

Major hurdles remain before the finding could be used as a cure. There is still no test that can detect vCJD infection before symptoms develop and no known drugs can switch off the production of healthy prions in humans.

"If there was a diagnostic test for humans that could pick the disease up early, hopefully there would be a potential for recovery with this treatment," Dr Malucci added. The study appears in the journal Neuron.

The UCL team is screening a vast array of drugs to identify if any can be used to stop prion production, but the next step in their research will investigate whether gene therapy can be used to switch off prion production in mice once they have developed prion disease.

This month, the government launched its first concerted effort to find out how common vCJD infection is in the general population by beginning vCJD tests on 100,000 pairs of tonsils gathered from operations around the country.

Source-Bio-Bio Technology
SRI
'"/>




Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Researchers Discover Protein That Causes Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... 22, 2017 , ... Silicon Valley startup Enke Life has ... Their electric toothbrushes aggressively attack oral bacteria by reducing dental plaque and other ... edge Enke technology with a premium timeless design, they want to redefine the ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for ... 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device ... of The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... of a new member survey conducted by the International Society of Hair ... from 2014 to 2016 rose 60 percent, with 635,189 procedures performed in 2016. ...
(Date:9/21/2017)... ... 21, 2017 , ... Innovatum will demonstrate capabilities of fully ... Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development addresses ... patient safety. , Microscan , a global technology leader in barcoding, ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly and ... will present new data for galcanezumab and lasmiditan, two ... the International Headache Society (IHC) taking place Sept. 7-10 ... Lilly will highlight new, long-term data from an open-label ... of galcanezumab (120 mg and 240 mg) for the ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: